MAY-262611

WAY-262611 is a wingless β-Catenin agonist that increases bone formation rate with an EC50 of 0.63 μM in TCF-Luciferase assay. WAY-262611 is also a Dkk1 inhibitor.


Cat. No.: EX-A2096	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	430	In-stock
250mg	550	In-stock
500mg	700	In-stock
1g	950	In-stock
5g	1950	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


CAS No.	1123231-07-1
Purity	>98%
Formula	C20H22N4
Mol Weight	318.4155
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Pelletier JC, et al. (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rate. J Med Chem. 2009 Nov 26;52(22):6962-5. [2]. L Enochson, et al. GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition. Osteoarthritis Cartilage. 2014 Apr;22(4):566-77.
CoA	CoA of MAY-262611

Smiles:	NCC1CCN(CC1)C1=NC=CC(=N1)C1=CC=C2C=CC=CC2=C1


		Search